Literature DB >> 11509526

New method of cardiac output measurement using ultrasound velocity dilution in rats.

N Veal1, F Moal, J Wang, E Vuillemin, F Oberti, E Roy, M Kaassis, R Trouvé, J L Saumet, P Calès.   

Abstract

The aim of this study was to validate a new technique for the measurement of cardiac output (CO) based on ultrasound and dilution (COUD) in anesthetized rats. A transit time ultrasound (TTU) probe was placed around the rat carotid artery, and ultrasound velocity dilution curves were generated on intravenous injections of saline. CO by COUD were calculated from the dilution curves for normal and portal hypertensive rats in which CO was known to be increased. COUD was compared with the radiolabeled microsphere method and with direct aortic TTU flowmetry for baseline CO and drug-induced CO variations. CO in direct aortic TTU flowmetry was the ascending aorta blood flow measured directly by TTU probe (normal use of TTU flowmetry). The reproducibility of COUD within the same animal was also determined under baseline conditions. COUD detected the known CO increase in portal hypertensive rats compared with normal rats. CO values by COUD were correlated with those provided by microsphere technique or direct aortic TTU flowmetry (adjusted r = 0.76, P < 10(-4) and r = 0.79, P < 0.05, respectively). Baseline CO values and terlipressin-induced CO variations were detected by COUD and the other techniques. Intra- and interobserver agreements for COUD were excellent (intraclass r = 0.99 and 0.98, respectively). COUD was reproducible at least 10 times in 20 min. COUD is an accurate and reproducible method providing low-cost, repetitive CO measurements without open-chest surgery. It can be used in rats as an alternative to the microsphere method and to direct aortic flowmetry.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509526     DOI: 10.1152/jappl.2001.91.3.1274

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  6 in total

1.  Quantitative blood flow measurements in the small animal cardiopulmonary system using digital subtraction angiography.

Authors:  MingDe Lin; Craig T Marshall; Yi Qi; Samuel M Johnston; Cristian T Badea; Claude A Piantadosi; G Allan Johnson
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

2.  Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension.

Authors:  Lionel Fizanne; Nicolas Régenet; Jianhua Wang; Frédéric Oberti; Frédéric Moal; Jerôme Roux; Yves Gallois; Sophie Michalak; Paul Calès
Journal:  Hepatol Int       Date:  2008-04-12       Impact factor: 6.047

3.  Hemodynamic effects of acute and chronic administration of vapreotide in rats with cirrhosis.

Authors:  Nary Veal; Frédéric Moal; Frédéric Oberti; Eric Vuillemin; Paul Calés
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

4.  Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.

Authors:  Frédéric Moal; Nary Veal; Eric Vuillemin; Eric Barrière; Jianhua Wang; Lionel Fizanne; Frédéric Oberti; Olivier Douay; Yves Gallois; Dominique Bonnefont-Rousselot; Marie Christine Rousselet; Paul Calès
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

5.  Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.

Authors:  Bingong Li; Zeqi Zheng; Yunfeng Wei; Menghong Wang; Jingtian Peng; Ting Kang; Xin Huang; Jian Xiao; Yong Li; Zhe Li
Journal:  Cardiovasc Diabetol       Date:  2011-07-29       Impact factor: 9.951

6.  Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.

Authors:  Mercedes Reboredo; Haisul C Y Chang; Roberto Barbero; Carlos M Rodríguez-Ortigosa; Francisco Pérez-Vizcaíno; Asunción Morán; Mónica García; Jesús M Banales; Norberto Carreño; Félix Alegre; Ignacio Herrero; Jorge Quiroga; Jesús Prieto; Bruno Sangro
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.